COVID-19 in a patient treated with eculizumab for aquaporin-4 neuromyelitis optica

por Cabal-Herrera, Ana Maria, Mateen, Farrah J.
Publicado 2021

Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Pathophysiology and Clinical Implications

por Cabal-Herrera, Ana Maria, Tassanakijpanich, Nattaporn, Salcedo-Arellano, Maria Jimena, Hagerman, Randi J.
Publicado 2020

Ataxia as the Major Manifestation of Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Case Series

por Salcedo-Arellano, Maria Jimena, Cabal-Herrera, Ana Maria, Tassanakijpanich, Nattaporn, McLennan, Yingratana A., Hagerman, Randi J.
Publicado 2020

Elevated FMR1-mRNA and lowered FMRP – A double-hit mechanism for psychiatric features in men with FMR1 premutations

por Schneider, Andrea, Winarni, Tri Indah, Cabal-Herrera, Ana María, Bacalman, Susan, Gane, Louise, Hagerman, Paul, Tassone, Flora, Hagerman, Randi
Publicado 2020

The International Fragile X Premutation Registry: building a resource for research and clinical trial readiness

por Hessl, David, Rosselot, Hilary, Miller, Robert, Espinal, Glenda, Famula, Jessica, Sherman, Stephanie L, Todd, Peter K, Cabal Herrera, Ana Maria, Lipworth, Karen, Cohen, Jonathan, Hall, Deborah A, Leehey, Maureen, Grigsby, Jim, Weber, Jayne Dixon, Alusi, Sundus, Wheeler, Anne, Raspa, Melissa, Hudson, Tamaro, Sobrian, Sonya K
Publicado 2022